STANDARDIZATION OF BLASTOCYSTIS HOMINIS DIAGNOSIS USING DIFFERENT STAINING TECHNIQUES
Main Article Content
Keywords
Blastocystis hominis, trichrome stain, iron hematoxylin, diagnostic accuracy, stool microscopy, parasitology.
Abstract
Background: Blastocystis hominis is one of the most frequently encountered intestinal protozoa worldwide, yet its diagnosis remains challenging due to its pleomorphic nature and lack of standardized detection methods.
Objective: The primary objective of this study was to evaluate and standardize different staining techniques for the detection of Blastocystis hominis in stool samples.
Methodology: This cross-sectional analytical study was conducted on 85 patients presenting with gastrointestinal complaints. Stool samples were collected and examined using multiple staining techniques, including trichrome, iron hematoxylin, Giemsa, and modified Ziehl–Neelsen stains. Results were compared against a composite reference standard, defined as positivity by at least one staining method.
Results: Out of 85 samples, Blastocystis hominis was detected in 34 (40.0%) cases by at least one staining method. Trichrome stain demonstrated the highest detection rate (36.5%), followed by iron hematoxylin (32.9%), Giemsa (28.2%), and modified Ziehl–Neelsen (11.8%). Diagnostic accuracy analysis showed trichrome to have a sensitivity of 91.2% and specificity of 96.1%, while iron hematoxylin had 82.3% sensitivity and 96.1% specificity. Inter-observer agreement was strong across all stains, with kappa values ranging from 0.86 to 0.91. No statistically significant association was observed between gastrointestinal symptoms and Blastocystis positivity.
Conclusion: It is concluded that trichrome staining is the most sensitive and practical method for routine detection of Blastocystis hominis, while iron hematoxylin remains a reliable but technically demanding alternative. Giemsa provided moderate results, whereas modified Ziehl–Neelsen was unsuitable for routine diagnosis.
References
2. Boutahar M, et al. “Prevalence of Blastocystis sp. in Morocco.” Parasite. 2023. Highlights the effectiveness of PCR over direct examination and culture in detecting Blastocystis.
3. Şahin M, Taş Cengiz Z, Halidi AG, Aydemir S. “Investigation of Blastocystis hominis Frequency in Patients with Diabetes by Microscopy and Conventional PCR Methods.” Iranian Journal of Parasitology. 2023. Compares native-Lugol, trichrome staining, and PCR for detection.
4. Maghawry A, et al. “Evaluation of Staining Methods Versus in-Vitro Cultivation for Blastocystis in Stool Samples.” ZU Medical Journal. 2023. Evaluated sensitivity/specificity of culture vs trichrome, MZN (Modified Ziehl-Neelsen), etc.
5. Sarwar Beg, Waleed Hassan Almalki, Fahmida Khatoon, Arshi Malik, Sarah Afaq, Hani Choudhry.Lipid- and polymer-based nanocomplexes in nucleic acid delivery as cancer vaccines,Drug Discovery Today,2021,ISSN 1359-6446
6. W Zhao, et al. “Molecular prevalence and subtype distribution of Blastocystis spp. in children with diarrhea compared to asymptomatic children, Wenzhou, China.” Parasite. 2024. This paper shows differences in detection rates by molecular vs clinical symptoms.
7. Sangani GS, et al. “Detection and subtyping of Blastocystis sp. in human and animals using high-resolution melting curve analysis (HRM).” PMC article. 2025. Provides a subtype distribution of Blastocystis and compares detection in human/animal hosts.
8. Hartuis S, et al. “The Novodiag® Stool parasites assay, an innovative high-plex detection tool: evaluation for Blastocystis spp. and others.” Parasite. 2022. Compares a newer assay vs routine methods; shows greatly improved detection for Blastocystis.
9. R Zamani, et al. “Comparison of diagnostic methods (wet mount, trichrome, FECT, PCR, in-vitro culture) for detection of Blastocystis spp. in Urmia, Iran.” 2021. Compares multiple microscopic and culture methods with PCR in an Iranian population.
10. Ye Beyhan, et al. “Detection of Blastocystis in ulcerative colitis, Crohn’s disease, and diarrhea patients.” 2023. Focuses on Blastocystis in GI disease contexts.
11. Elhadad H, et al. “Assessment of immunological and hematological parameters in Blastocystis species-infected chronic leukemic patients.” Gut Pathogens. 2025. Includes microscopic detection & coproantigen, addresses infection in immunocompromised group.
12. “Epidemiology of Blastocystis Infection: A Review of Data from Poland” by Rudzińska M, et al. Pathogens. 2023. Reviews prevalence, genotypic variation, diagnostic variability across human/animal/water sources.
13. Viesy S, et al. “The Prevalence of Blastocystis spp. and Its Relationship with Gastrointestinal Disorders and Risk Factors” (Ilam, Iran). 2022. Uses wet mount & trichrome for confirmation in large sample (n=1000).
14. Zahid Balouch FK, editor. Therapeutic Proteins Against Human Diseases [Internet]. Springer Nature Singapore; 2022. Available from: http://dx.doi.org/10.1007/978-981-16-7897-4
15. Molecular characterization and subtype analysis of Blastocystis in captive wildlife (bird park, China). Cui Z, et al. Parasite. 2025. Around 13.7% prevalence in animals; subtype diversity.
16. Fahmida Khatoon.Recent techniques based on the utilization of DNA and autosomal single nucleotide polymorphisms for identifying humans.Gomal J Med Sci Apr - Jun 2019;17(2):58-62.
17. (Re-use, but distinct point) “Prevalence and distribution of subtypes of Blastocystis in Asiatic brush-tailed porcupines, bamboo rats.” Zhao W, et al. 2023. This gives subtype in non-human species.
18. High rates of Dientamoeba fragilis and Blastocystis species in large cohort (36,008 children) using stool PCR testing. ScienceDirect. Shasha D, et al. 2024. Highlights prevalence by modern molecular detection.
19. “Comparison of diagnostic techniques for Blastocystis species detection” by Zamani etc. (again #8) but useful for staining vs culture vs PCR.
20. “Detection of *Blastocystis in clinical stool specimens using PCR vs microscopy and in vitro culture.” Padukone S, et al. 2018. Slightly older but still within 5-7 yrs; useful for staining/culture vs molecular.
21. Khtoon, F. (2025) 'Environmental and Genetic Influences on Placental Morphogenesis: Integrating Maternal Health and Fetal Outcomes' Journal of Pioneering Medical Sciences 14(5), pp. 156-163.Journal of Pioneering Medical Sciences 14(S1), pp. 204-209.pg204-209 ,Pakistan , 5 June 2025.
22. Zamani R, Khademvatan S, Abasi E, et al. (Urmia, Iran) – detailed in #8 ‒ but one can use as separate if different method emphasis.